AST

Asterias Biotherapeutics Inc. Series A
AST

Overview Fund Activity
Delisted

AST was delisted on the 7th of March, 2019.

Back to rankings

56 hedge funds and large institutions have $18M invested in Asterias Biotherapeutics Inc. Series A in 2015 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 10 closing their positions.

Holders
56
Holders Change
-2
Holders Change %
-3.45%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
14
Reduced
11
Closed
10
Calls
–
Puts
$69K
Net Calls
-$69K
Net Calls Change
+$52K

Top Buyers

1
Thrivent Financial for Lutherans
1
Thrivent Financial for Lutherans
Minnesota
$1.04M
2
BCM
2
Bridgeway Capital Management
Texas
$582K
3
SIM
3
Spark Investment Management
New York
$269K
4
State Street
4
State Street
Massachusetts
$358K
5
VKH
5
Virtu KCG Holdings
New York
$75K

Top Sellers

1
AQR Capital Management
1
AQR Capital Management
Connecticut
$0
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.77M
3
Goldman Sachs
3
Goldman Sachs
New York
$0
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$0
5
Jane Street
5
Jane Street
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PP
51
Paloma Partners
Connecticut
– -$54K -13,966 Closed
RhumbLine Advisers
52
RhumbLine Advisers
Massachusetts
– -$43K -11,199 Closed
SG Americas Securities
53
SG Americas Securities
New York
– -$42K -10,735 Closed
M&T Bank
54
M&T Bank
New York
– -$39K -10,028 Closed
1 2
3